Steris Applied Sterilization Technologies

Executive Summary

STERIS Applied Sterilization Technologies (STERIS AST) is a global leader in contract sterilization and laboratory testing for medical device and pharmaceutical clients. Operating a technology-neutral portfolio including gamma, electron beam, X-ray, ethylene oxide, vaporized hydrogen peroxide, and steam sterilization, the company enables clients to achieve regulatory compliance across markets. With a valuation over $21 billion and strong recurring revenue from long-term contracts, STERIS AST benefits from secular trends toward outsourcing sterilization due to increasing regulatory complexity and demand for sterile medical products. The company's broad technology platform and global footprint position it to capture growth as new modalities like X-ray gain adoption. However, competition and potential shifts in sterilization preferences require continuous innovation.

Upcoming Catalysts (preview)

• Q2 2027Expansion of X-ray sterilization capacity in North America80% success
• Q4 2026Adoption of new ethylene oxide emission regulations favoring contract sterilizers70% success
• Q1 2027Major long-term contract renewal with a top-10 medical device manufacturer90% success